Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.

Zumwalde NA, Haag JD, Gould MN, Gumperz JE.

Breast Cancer Res. 2018 Sep 12;20(1):111. doi: 10.1186/s13058-018-1036-5.

2.

Impact of Pharmacist-Provided Medication Therapy Management on Healthcare Quality and Utilization in Recently Discharged Elderly Patients.

Haag JD, Davis AZ, Hoel RW, Armon JJ, Odell LJ, Dierkhising RA, Takahashi PY.

Am Health Drug Benefits. 2016 Jul;9(5):259-68.

3.

The Non-coding Mammary Carcinoma Susceptibility Locus, Mcs5c, Regulates Pappa Expression via Age-Specific Chromatin Folding and Allele-Dependent DNA Methylation.

Henning AN, Haag JD, Smits BM, Gould MN.

PLoS Genet. 2016 Aug 18;12(8):e1006261. doi: 10.1371/journal.pgen.1006261. eCollection 2016 Aug.

4.

Going Beyond Administrative Data: Retrospective Evaluation of an Algorithm Using the Electronic Health Record to Help Identify Bleeding Events Among Hospitalized Medical Patients on Warfarin.

Moriarty JP, Daniels PR, Manning DM, O'Meara JG, Ou NN, Berg TM, Haag JD, Roellinger DL, Naessens JM.

Am J Med Qual. 2017 Jul/Aug;32(4):391-396. doi: 10.1177/1062860616660757. Epub 2016 Jul 25.

PMID:
27455999
5.

Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate.

Zumwalde NA, Haag JD, Sharma D, Mirrielees JA, Wilke LG, Gould MN, Gumperz JE.

Cancer Prev Res (Phila). 2016 Apr;9(4):305-16. doi: 10.1158/1940-6207.CAPR-15-0370-T. Epub 2016 Jan 25.

6.

The gene desert mammary carcinoma susceptibility locus Mcs1a regulates Nr2f1 modifying mammary epithelial cell differentiation and proliferation.

Smits BM, Haag JD, Rissman AI, Sharma D, Tran A, Schoenborn AA, Baird RC, Peiffer DS, Leinweber DQ, Muelbl MJ, Meilahn AL, Eichelberg MR, Leng N, Kendziorski C, John MC, Powers PA, Alexander CM, Gould MN.

PLoS Genet. 2013 Jun;9(6):e1003549. doi: 10.1371/journal.pgen.1003549. Epub 2013 Jun 13.

7.

EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments.

Leng N, Dawson JA, Thomson JA, Ruotti V, Rissman AI, Smits BM, Haag JD, Gould MN, Stewart RM, Kendziorski C.

Bioinformatics. 2013 Apr 15;29(8):1035-43. doi: 10.1093/bioinformatics/btt087. Epub 2013 Feb 21. Erratum in: Bioinformatics. 2013 Aug 15;29(16):2073.

8.

Effective flow cytometric phenotyping of cells using minimal amounts of antibody.

Sharma D, Eichelberg MR, Haag JD, Meilahn AL, Muelbl MJ, Schell K, Smits BM, Gould MN.

Biotechniques. 2012 Jul;53(1):57-60. doi: 10.2144/0000113854.

9.

Quantification of epithelial cell differentiation in mammary glands and carcinomas from DMBA- and MNU-exposed rats.

Sharma D, Smits BM, Eichelberg MR, Meilahn AL, Muelbl MJ, Haag JD, Gould MN.

PLoS One. 2011;6(10):e26145. doi: 10.1371/journal.pone.0026145. Epub 2011 Oct 12.

10.

An insulator loop resides between the synthetically interacting elements of the human/rat conserved breast cancer susceptibility locus MCS5A/Mcs5a.

Smits BM, Traun BD, Devries TL, Tran A, Samuelson D, Haag JD, Gould M.

Nucleic Acids Res. 2012 Jan;40(1):132-47. doi: 10.1093/nar/gkr610. Epub 2011 Sep 13.

11.

The non-protein coding breast cancer susceptibility locus Mcs5a acts in a non-mammary cell-autonomous fashion through the immune system and modulates T-cell homeostasis and functions.

Smits BM, Sharma D, Samuelson DJ, Woditschka S, Mau B, Haag JD, Gould MN.

Breast Cancer Res. 2011 Aug 16;13(4):R81. doi: 10.1186/bcr2933.

12.

Physical confirmation and mapping of overlapping rat mammary carcinoma susceptibility QTLs, Mcs2 and Mcs6.

Sanders J, Haag JD, Samuelson DJ.

PLoS One. 2011;6(5):e19891. doi: 10.1371/journal.pone.0019891. Epub 2011 May 18.

13.

Mcs5c: a mammary carcinoma susceptibility locus located in a gene desert that associates with tenascin C expression.

Veillet AL, Haag JD, Remfert JL, Meilahn AL, Samuelson DJ, Gould MN.

Cancer Prev Res (Phila). 2011 Jan;4(1):97-106. doi: 10.1158/1940-6207.CAPR-10-0187.

14.

Patient care services in rural Minnesota community pharmacies.

Haag JD, Stratton TP.

J Am Pharm Assoc (2003). 2010 Jul-Aug;50(4):508-16. doi: 10.1331/JAPhA.2010.09134.

PMID:
20621869
15.

A short-term rat mammary carcinogenesis model for the prevention of hormonally responsive and nonresponsive in situ carcinomas.

Woditschka S, Haag JD, Sullivan R, Gould MN.

Cancer Prev Res (Phila). 2009 Feb;2(2):153-60. doi: 10.1158/1940-6207.CAPR-08-0114.

16.

Freund's vaccine adjuvant promotes Her2/neu breast cancer.

Cotroneo MS, Haag JD, Stapel NR, Waller JL, Woditschka S, Gould MN.

BMC Cancer. 2009 Jan 14;9:19. doi: 10.1186/1471-2407-9-19.

17.

Chemopreventive effects of celecoxib are limited to hormonally responsive mammary carcinomas in the neu-induced retroviral rat model.

Woditschka S, Haag JD, Mau B, Lubet RA, Gould MN.

Breast Cancer Res. 2008;10(1):R18. doi: 10.1186/bcr1864. Epub 2008 Feb 15.

18.

Genetically engineered rat models for breast cancer.

Smits BM, Cotroneo MS, Haag JD, Gould MN.

Breast Dis. 2007;28:53-61. Review.

PMID:
18057543
19.

Rat Mcs5a is a compound quantitative trait locus with orthologous human loci that associate with breast cancer risk.

Samuelson DJ, Hesselson SE, Aperavich BA, Zan Y, Haag JD, Trentham-Dietz A, Hampton JM, Mau B, Chen KS, Baynes C, Khaw KT, Luben R, Perkins B, Shah M, Pharoah PD, Dunning AM, Easton DF, Ponder BA, Gould MN.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6299-304. Epub 2007 Apr 2.

20.

A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer.

Amos-Landgraf JM, Kwong LN, Kendziorski CM, Reichelderfer M, Torrealba J, Weichert J, Haag JD, Chen KS, Waller JL, Gould MN, Dove WF.

Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4036-41. Epub 2007 Feb 27.

21.

Characterizing a rat Brca2 knockout model.

Cotroneo MS, Haag JD, Zan Y, Lopez CC, Thuwajit P, Petukhova GV, Camerini-Otero RD, Gendron-Fitzpatrick A, Griep AE, Murphy CJ, Dubielzig RR, Gould MN.

Oncogene. 2007 Mar 8;26(11):1626-35. Epub 2006 Sep 11.

PMID:
16964288
22.

Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomas.

Woditschka S, Haag JD, Waller JL, Monson DM, Hitt AA, Brose HL, Hu R, Zheng Y, Watson PA, Kim K, Lindstrom MJ, Mau B, Steele VE, Lubet RA, Gould MN.

Cancer Res. 2006 Jul 1;66(13):6884-91.

23.

The Mcs7 quantitative trait locus is associated with an increased susceptibility to mammary cancer in congenic rats and an allele-specific imbalance.

Cotroneo MS, Merry GM, Haag JD, Lan H, Shepel LA, Gould MN.

Oncogene. 2006 Aug 17;25(36):5011-7. Epub 2006 Mar 27.

PMID:
16568087
24.

A dynamical systems analysis of the indirect response model with special emphasis on time to peak response.

Peletier LA, Gabrielsson J, Haag Jd.

J Pharmacokinet Pharmacodyn. 2005 Aug;32(3-4):607-54.

PMID:
16307206
25.
26.
28.

On the utility of pooling biological samples in microarray experiments.

Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN.

Proc Natl Acad Sci U S A. 2005 Mar 22;102(12):4252-7. Epub 2005 Mar 8.

29.

Congenic rats reveal three independent Copenhagen alleles within the Mcs1 quantitative trait locus that confer resistance to mammary cancer.

Haag JD, Shepel LA, Kolman BD, Monson DM, Benton ME, Watts KT, Waller JL, Lopez-Guajardo CC, Samuelson DJ, Gould MN.

Cancer Res. 2003 Sep 15;63(18):5808-12.

30.

Physical evidence of Mcs5, a QTL controlling mammary carcinoma susceptibility, in congenic rats.

Samuelson DJ, Haag JD, Lan H, Monson DM, Shultz MA, Kolman BD, Gould MN.

Carcinogenesis. 2003 Sep;24(9):1455-60. Epub 2003 Jul 4.

PMID:
12844486
31.

Production of knockout rats using ENU mutagenesis and a yeast-based screening assay.

Zan Y, Haag JD, Chen KS, Shepel LA, Wigington D, Wang YR, Hu R, Lopez-Guajardo CC, Brose HL, Porter KI, Leonard RA, Hitt AA, Schommer SL, Elegbede AF, Gould MN.

Nat Biotechnol. 2003 Jun;21(6):645-51. Epub 2003 May 18.

PMID:
12754522
32.
33.

Genetic loci controlling breast cancer susceptibility in the Wistar-Kyoto rat.

Lan H, Kendziorski CM, Haag JD, Shepel LA, Newton MA, Gould MN.

Genetics. 2001 Jan;157(1):331-9.

34.

ras gene mutations are absent in NMU-induced mammary carcinomas from aging rats.

Thompson TA, Haag JD, Gould MN.

Carcinogenesis. 2000 Oct;21(10):1917-22.

PMID:
11023551
35.

Linkage mapping of rat chromosome 5 markers generated from chromosome-specific libraries.

Lan H, Shepel LA, Haag JD, Gould MN.

Mamm Genome. 1999 Jul;10(7):687-91.

PMID:
10384040
36.

Precocious differentiation of the virgin Wistar-Kyoto rat mammary gland.

Benton ME, Chen KS, Haag JD, Sattler CA, Gould MN.

Endocrinology. 1999 Jun;140(6):2659-71.

PMID:
10342856
37.
38.

A comparative analysis of allelic imbalance events in chemically induced rat mammary, colon, and bladder tumors.

Haag JD, Brasic GM, Shepel LA, Newton MA, Grubbs CJ, Lubet RA, Kelloff GJ, Gould MN.

Mol Carcinog. 1999 Jan;24(1):47-56.

PMID:
10029410
39.

Heterogeneous expression of the lipocalin NGAL in primary breast cancers.

Stoesz SP, Friedl A, Haag JD, Lindstrom MJ, Clark GM, Gould MN.

Int J Cancer. 1998 Dec 18;79(6):565-72.

40.

On the statistical analysis of allelic-loss data.

Newton MA, Gould MN, Reznikoff CA, Haag JD.

Stat Med. 1998 Jul 15;17(13):1425-45.

PMID:
9695190
41.

Mapping of 55 new rat microsatellite markers from chromosome-specific libraries.

Shepel LA, Lan H, Brasic GM, Gheen ME, Hsu LC, Haag JD, Gould MN.

Mamm Genome. 1998 Aug;9(8):622-8. Erratum in: Mamm Genome 1998 Nov;9(11):925.

PMID:
9680381
42.

Genetic identification of multiple loci that control breast cancer susceptibility in the rat.

Shepel LA, Lan H, Haag JD, Brasic GM, Gheen ME, Simon JS, Hoff P, Newton MA, Gould MN.

Genetics. 1998 May;149(1):289-99. Erratum in: Genetics 1998 Jul;149(3):1627.

43.

Genetic linkage mapping of 11 novel DNA markers and the ceruloplasmin (Cp) gene on rat chromosome 2.

Shepel LA, Fleming RE, Haag JD, Brasic GM, Gheen ME, Simon JS, Gould MN.

Cytogenet Cell Genet. 1997;79(3-4):176-8.

PMID:
9605844
45.

Cloning, genetic mapping and expression studies of the rat Brca1 gene.

Chen KS, Shepel LA, Haag JD, Heil GM, Gould MN.

Carcinogenesis. 1996 Aug;17(8):1561-6.

PMID:
8761410
46.

Inherited susceptibility and acquired allelic imbalance in rat mammary carcinogenesis.

Gould MN, Lubet RA, Kelloff GJ, Haag JD.

J Cell Biochem Suppl. 1996;25:37-40. Review.

PMID:
9027596
47.

Limonene chemoprevention of mammary carcinoma induction following direct in situ transfer of v-Ha-ras.

Gould MN, Moore CJ, Zhang R, Wang B, Kennan WS, Haag JD.

Cancer Res. 1994 Jul 1;54(13):3540-3.

48.

Human metabolism of the experimental cancer therapeutic agent d-limonene.

Crowell PL, Elson CE, Bailey HH, Elegbede A, Haag JD, Gould MN.

Cancer Chemother Pharmacol. 1994;35(1):31-7.

PMID:
7987974
49.

Mammary carcinoma regression induced by perillyl alcohol, a hydroxylated analog of limonene.

Haag JD, Gould MN.

Cancer Chemother Pharmacol. 1994;34(6):477-83.

PMID:
7923558
50.

ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.

Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN.

Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8977-81.

Supplemental Content

Support Center